{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:54:44Z","timestamp":1793228084264,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy and is associated with aggressive side effects on patients. This study evaluated a new intra-tumor-targeted drug delivery method for the treatment of OSCC induced on the dorsum of the tongue in white mice. The induced tumors were examined by needle biopsy. A targeted anticancer drug (Cetuximab) and [Cisplatin and 5 Fluorouracil (5-FU)] chemotherapeutic agents were loaded on polyethylene glycol-polylactide-polyethylene glycol (PEG-PLA-PEG) nanoparticles (NPs) designed for intralesional injection while systemic administration was used as control. Fourier transform infrared spectroscopy (FTIR) was performed to study NP chemical structure, a drug release profile was conducted to study release kinetics, and histopathological evaluation was performed before and after treatment to evaluate tissue reactions (n-28, \u03ac\u2009=\u20090.05). The drug release profile was characteristic of the chemotherapeutic agent showing early quick ascend followed by sustained slow release. FTIR peaks identified the polymeric structure of the drug nano-carrier. Histopathologic examination of chemically induced OSCC revealed different grades ranging from non-invasive to invasive stages of OSCC. Intra-tumoral test group revealed significant remission of observed cancer grade compared to the systemically administered group (X<jats:sup>2<\/jats:sup>\u2009=\u200912.63, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Finally, using synthesized PEG\u2013PLA\u2013PEG NPs for intralesional injection is a promising route for the treatment of OSCC.<\/jats:p>","DOI":"10.1038\/s41598-023-38230-6","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T10:02:19Z","timestamp":1690279339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Shimaa A.","family":"Elsaady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa N.","family":"Aboushelib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam","family":"Al-Wakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"38230_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/biom11030392","volume":"11","author":"M Kabir","year":"2021","unstructured":"Kabir, M. et al. Potential role of curcumin and its nano formulations to treat various types of cancers. Biomolecules 11, 392 (2021).","journal-title":"Biomolecules"},{"key":"38230_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299 (2019).","journal-title":"Nature"},{"key":"38230_CR3","doi-asserted-by":"publisher","first-page":"12618","DOI":"10.1111\/ecc.12618","volume":"26","author":"D Lorusso","year":"2017","unstructured":"Lorusso, D. et al. Patients\u2019 perception of chemotherapy side effects: Expectations, doctor-patient communication, and impact on quality of life\u2014an Italian survey. Eur. J. Cancer Care 26, 12618 (2017).","journal-title":"Eur. J. Cancer Care"},{"issue":"3","key":"38230_CR4","first-page":"33","volume":"58","author":"T Hassan","year":"2021","unstructured":"Hassan, T., Huang, X., Zhou, C., Khan, M. S. G. & Saeed, S. Nanoparticles in cancer treatment: A narrative review. Proc. Pak. Acad. Sci. Life Environ. Sci. 58(3), 33\u201350 (2021).","journal-title":"Proc. Pak. Acad. Sci. Life Environ. Sci."},{"issue":"11","key":"38230_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc.2017.84","volume":"17","author":"J Rotow","year":"2017","unstructured":"Rotow, J. & Bivona, T. G. Understanding and targeting resistance mechanisms in NSCLC. Nat. Rev. Cancer 17(11), 637\u2013658 (2017).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"38230_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.5306\/wjco.v5.i5.1048","volume":"5","author":"T Yano","year":"2014","unstructured":"Yano, T. et al. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J. Clin. Oncol. 5(5), 1048\u20131054 (2014).","journal-title":"World J. Clin. Oncol."},{"key":"38230_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40580-021-00282-7","volume":"8","author":"JA Kemp","year":"2021","unstructured":"Kemp, J. A. & Kwon, Y. J. Cancer nanotechnology: current status and perspectives. Nano Converg. 8, 34. https:\/\/doi.org\/10.1186\/s40580-021-00282-7 (2021).","journal-title":"Nano Converg."},{"key":"38230_CR8","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/jcp.29126","volume":"235","author":"A Aghebati-Maleki","year":"2020","unstructured":"Aghebati-Maleki, A. et al. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. J. Cell. Physiol. 235, 1962\u20131972 (2020).","journal-title":"J. Cell. Physiol."},{"key":"38230_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/21691401.2017.1290648","volume":"46","author":"NA Nasab","year":"2018","unstructured":"Nasab, N. A., Kumleh, H. H., Beygzadeh, M., Teimourian, S. & Kazemzad, M. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif. Cells Nanomed. Biotechnol. 46, 75\u201381 (2018).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"38230_CR10","first-page":"599","volume":"11","author":"J Kashima","year":"2019","unstructured":"Kashima, J., Kitadai, R. & Okuma, Y. Molecular and morphological profiling of lung cancer: A foundation for \u201cnext-generation\u201d. Pathol Oncolo Cancers 11(5), 599 (2019).","journal-title":"Pathol Oncolo Cancers"},{"key":"38230_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong, W. H. & Borm, P. J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 3, 133\u2013149 (2008).","journal-title":"Int. J. Nanomed."},{"key":"38230_CR12","first-page":"1","volume-title":"Oral Mucosal Drug Delivery and Therapy","author":"PT Johnston","year":"2015","unstructured":"Johnston, P. T. Anatomy and Physiology of the Oral Mucosa. In Oral Mucosal Drug Delivery and Therapy (eds Rathbone, J. M. et al.) 1\u201315 (Springer, 2015)."},{"issue":"3","key":"38230_CR13","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1002\/btm2.10143","volume":"4","author":"AC Anselmo","year":"2019","unstructured":"Anselmo, A. C. & Mitragotri, S. Nanoparticles in the clinic: An update. Bioeng. Transl. Med. 4(3), 10143\u201310143 (2019).","journal-title":"Bioeng. Transl. Med."},{"key":"38230_CR14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.biopha.2018.07.102","volume":"106","author":"MM Badran","year":"2018","unstructured":"Badran, M. M. et al. Novel docetaxel chitosan-coated PLGA\/PCL nanoparticles with magnified cytotoxicity and bioavailability. Biomed. Pharmacother. 106, 1461\u20131468 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"38230_CR15","first-page":"10","volume":"22","author":"GR Thampi","year":"2014","unstructured":"Thampi, G. R., Godwin, S. & Harish, G. Design and characterization of nanoparticulate drug delivery system of an anticancer drug: Imatinib mesylate. Indian J. Res. Pharm. Biotechnol. 22, 10\u201382 (2014).","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"key":"38230_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.msec.2017.10.003","volume":"83","author":"C Ye","year":"2018","unstructured":"Ye, C. & Chi, H. A review of recent progress in drug and protein encapsulation: Approaches, applications and challenges. Mater. Sci. Eng. C 83, 233\u2013246 (2018).","journal-title":"Mater. Sci. Eng. C"},{"key":"38230_CR17","first-page":"77","volume":"63","author":"N Nishiyama","year":"2003","unstructured":"Nishiyama, N. et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Can. Res. 63, 77\u201383 (2003).","journal-title":"Can. Res."},{"key":"38230_CR18","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.2147\/IJN.S215137","volume":"15","author":"Wu Pingping","year":"2020","unstructured":"Pingping, Wu., Zhu, H., Zhuang, Y., Sun, X. & Ning, Gu. Effects of 131Ilabeled and 5Fu-loaded multifunctional nanoparticles in colorectal cancer. Int. J. Nanomed. 15, 2777\u20132787 (2020).","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"38230_CR19","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.5012\/bkcs.2012.33.5.1638","volume":"33","author":"H Zhao","year":"2012","unstructured":"Zhao, H. et al. Preparation and characterization of PEG\/PLA multiblock and triblock copolymer. Bull. Korean Chem. Soc. 33(5), 1638\u20131642 (2012).","journal-title":"Bull. Korean Chem. Soc."},{"key":"38230_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/A:1020200822435","volume":"9","author":"D Garlotta","year":"2001","unstructured":"Garlotta, D. A literature review of poly (lactic acid). J. Poly. Environ. 9, 63\u201384 (2001).","journal-title":"J. Poly. Environ."},{"key":"38230_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016016272","volume":"34","author":"SA Gharat","year":"2016","unstructured":"Gharat, S. A., Momin, M. & Bhavsar, C. Oral squamous cell carcinoma: Current treatment strategies and nanotechnology-based approaches for prevention and therapy. Critical Rev. Ther. Drug Carrier Syst. 34, 363\u2013400 (2016).","journal-title":"Critical Rev. Ther. Drug Carrier Syst."},{"key":"38230_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/pharmaceutics11070302","volume":"17","author":"F Ketabat","year":"2019","unstructured":"Ketabat, F. et al. Controlled drug delivery systems for oral cancer treatment-current status and future perspectives. Pharmaceutics 17, 302 (2019).","journal-title":"Pharmaceutics"},{"key":"38230_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/wnan.1332","volume":"75","author":"S Movassaghian","year":"2015","unstructured":"Movassaghian, S., Merkel, O. M. & Torchilin, V. P. Applications of polymer micelles for imaging and drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol 75, 691\u2013707 (2015).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol"},{"key":"38230_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12033-014-9816-3","volume":"573","author":"MA Ghaz-Jahanian","year":"2015","unstructured":"Ghaz-Jahanian, M. A., Abbaspour-Aghdam, F., Anarjan, N., Berenjian, A. & Jafarizadeh-Malmiri, H. Application of chitosan-based nanocarriers in tumor-targeted drug delivery. Mol. Biotechnol. 573, 201\u2013218 (2015).","journal-title":"Mol. Biotechnol."},{"key":"38230_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4155\/tde-2020-0008","volume":"10","author":"N Majumder","year":"2020","unstructured":"Majumder, N., Das, N. G. & Das, S. K. Polymeric micelles for anticancer drug delivery. Ther. Deliv. 10, 613\u2013635 (2020).","journal-title":"Ther. Deliv."},{"key":"38230_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","volume":"244","author":"P Zhang","year":"2016","unstructured":"Zhang, P., Sun, F., Liu, S. & Jiang, S. Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation. J. Control. Release 244, 184\u2013193 (2016).","journal-title":"J. Control. Release"},{"issue":"10","key":"38230_CR27","first-page":"742","volume":"6","author":"R Mehra","year":"2008","unstructured":"Mehra, R., Cohen, R. B. & Burtness, B. A. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clin. Adv. Hematol. Oncol. 6(10), 742\u2013750 (2008).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"38230_CR28","first-page":"55","volume":"97","author":"M Yu","year":"2015","unstructured":"Yu, M. & Zheng, J. Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano 97, 55\u201374 (2015).","journal-title":"ACS Nano"},{"key":"38230_CR29","doi-asserted-by":"publisher","first-page":"23346","DOI":"10.1016\/j.msec.2017.10.003","volume":"83","author":"C Ye","year":"2018","unstructured":"Ye, C. & Chi, H. A review of recent progress in drug and protein encapsulation: Approaches, applications and challenges. Mater. Sci. Eng. 83, 23346 (2018).","journal-title":"Mater. Sci. Eng."},{"key":"38230_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fonc.2019.00668","volume":"9","author":"J Guigay","year":"2019","unstructured":"Guigay, J. et al. The evolving role of taxanes in combination with cetuximab for the treatment of recurrent and\/or metastatic squamous cell carcinoma of the head and neck: evidence, advantages, and future directions. Front. Oncol. 9, 66\u201368 (2019).","journal-title":"Front. Oncol."},{"key":"38230_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.progpolymsci.2022.101556","volume":"130","author":"B Kost","year":"2022","unstructured":"Kost, B. et al. The influence of the functional end groups on the properties of polylactide-based materials. Prog. Polym. Sci. 130, 101\u2013556 (2022).","journal-title":"Prog. Polym. Sci."},{"issue":"2","key":"38230_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/nn9014032","volume":"1","author":"CMJ Hu","year":"2010","unstructured":"Hu, C. M. J., Aryal, S. & Zhang, L. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther. Deliv. 1(2), 323\u2013334. https:\/\/doi.org\/10.1021\/nn9014032 (2010).","journal-title":"Ther. Deliv."},{"issue":"10","key":"38230_CR33","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1007\/s11051-014-2648-z","volume":"16","author":"S Chen","year":"2014","unstructured":"Chen, S. et al. siRNA-loaded PEGylated porous silicon nanoparticles for lung cancer therapy. J. Nanopart Res. 16(10), 2648 (2014).","journal-title":"J. Nanopart Res."},{"issue":"2","key":"38230_CR34","first-page":"1","volume":"43","author":"MM Abdelhamid","year":"2021","unstructured":"Abdelhamid, M. M., Ismail, M. A. & Abdelaal, M. Y. Fabrication and investigation of bichalcophenes-loaded polymers. MJC 43(2), 1\u20138 (2021).","journal-title":"MJC"},{"issue":"2","key":"38230_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1021\/cm0619398","volume":"19","author":"S Zhou","year":"2007","unstructured":"Zhou, S. et al. Hydrogen bonding interaction of poly (D, L-Lactide)\/hydroxyapatite nanocomposites. Chem. Mater. 19(2), 247\u2013253 (2007).","journal-title":"Chem. Mater."},{"issue":"7","key":"38230_CR36","first-page":"1910","volume":"20","author":"SR Mallery","year":"2014","unstructured":"Mallery, S. R. et al. Topical application of a mucoadhesive freeze-dried black raspberry gel induces clinical and histologic regression and reduces loss of heterozygosity events in premalignant oral intraepithelial lesions: Results from a multicentered. Placebo-Controll. Clin. Trial. Clin. Cancer Res. 20(7), 1910\u20131924 (2014).","journal-title":"Placebo-Controll. Clin. Trial. Clin. Cancer Res."},{"key":"38230_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.colsurfb.2012.11.025","volume":"104","author":"D Palmer","year":"2013","unstructured":"Palmer, D. et al. Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose. Colloids Surf. B Biointerfaces 104, 174\u2013180 (2013).","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"38230_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/1477-3163.85185","volume":"10","author":"S Mallery","year":"2011","unstructured":"Mallery, S., Desai, K.-G., Holpuch, A. & Schwendeman, S. Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials. J. Carcinog. 10(1), 23 (2011).","journal-title":"J. Carcinog."},{"key":"38230_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/carcin\/bgi241","volume":"73","author":"R Suzuki","year":"2006","unstructured":"Suzuki, R. et al. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: Its potential use for preclinical chemoprevention studies. Carcinogenesis 73, 619\u2013630 (2006).","journal-title":"Carcinogenesis"},{"key":"38230_CR40","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mc.20531","volume":"89","author":"JF Wilkey","year":"2009","unstructured":"Wilkey, J. F. et al. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol. Carcinog. 89, 853\u2013861 (2009).","journal-title":"Mol. Carcinog."},{"key":"38230_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0030-4220(77)90304-8","volume":"44","author":"JW Eveson","year":"1977","unstructured":"Eveson, J. W. & MacDonald, D. G. Effects of the water-soluble carcinogen 4-nitroquinoline Noxide on hamster lingual mucosa. Oral Surg. Oral Med. Oral Pathol. 44, 600\u2013605 (1977).","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"38230_CR42","first-page":"932","volume":"24","author":"J-P Foy","year":"2016","unstructured":"Foy, J.-P. et al. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Oncotarget 24, 932\u2013945 (2016).","journal-title":"Oncotarget"},{"key":"38230_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4067\/S0717-95022012000100055","volume":"301","author":"CAR Mart\u00ednez","year":"2012","unstructured":"Mart\u00ednez, C. A. R. 4NQO carcinogenesis: A model of oral squamous cell carcinoma. Int. J. Morphol. 301, 309\u2013314 (2012).","journal-title":"Int. J. Morphol."},{"key":"38230_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jomfp.JOMFP_13_19","volume":"231","author":"K Ranganathan","year":"2019","unstructured":"Ranganathan, K. & Kavitha, L. Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders. J. Oral Maxillofacial Pathol. 231, 19 (2019).","journal-title":"J. Oral Maxillofacial Pathol."},{"key":"38230_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/cas.12079","volume":"43","author":"K Endo","year":"2013","unstructured":"Endo, K. et al. Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma. Cancer Sci. 43, 369\u2013374 (2013).","journal-title":"Cancer Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38230-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T10:07:10Z","timestamp":1690279630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38230"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38230-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"18 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11984"}}